Valeant Pharma (VRX) Pearson Said to Have Sold 5M Shares - CNBC
CNBC Scott Wapner reports Valeant Pharma (NYSE: VRX) Pearson unloaded much more of his holdings than originally thought. Nearly 5m shares and in the money options worth $96.8m.
Seems $VRX CEO Pearson unloaded much more of his holdings than originally thought. Nearly 5m shares and in the money options worth $96.8m!
— Scott Wapner (@ScottWapnerCNBC) July 13, 2016
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Adds Four Names to Catalyst Call List
- Microsoft Replaces OpenAI, Anthropic With Own AI in Some Apps - Bloomberg
- Investment Firm Eqt Seeks To Raise $2.5 Billion In Second Pan-asia, Mid-cap Buyout Fund, Sources Say - Reuters
Create E-mail Alert Related Categories
Insider Trades, Short Sales, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share